Clinical Trial

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

Name: A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping — clinical trial record (NCT07511114)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Evaluate the efficacy and safety of C Pola R-CHP+X compared to CR-CHOP in the treatment of previously untreated patients with DEL

Trial Details

NCT Number	NCT07511114
Lead Sponsor	Ruijin Hospital
Conditions	DLBCL - Diffuse Large B Cell Lymphoma, Double Expressor Lymphoma
Enrollment	156 participants
Start Date	2026-03-31
Primary Completion	2028-03-31 (estimated)
Study Completion	2030-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-06